obesity - Search News

Novo Nordisk defends next-gen obesity drug CagriSema, details new trial

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data published in December that disappointed investors and wiped $125 billion from its market value.

The New York Times · 3d

Novo Nordisk Annual Sales Jump on Higher Demand for Obesity Drugs

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.

The Financial Times · 3d

Obesity drug sales help Novo Nordisk beat expectations

Sales of Novo Nordisk’s obesity drug, Wegovy, rose by more than 50 per cent last year, helping the Danish drugmaker beat revenue expectations. The company on Wednesday reported that net sales increased by 26 per cent year on year in 2024 to DKr290bn ($40bn),

Reuters · 4d

Novo Nordisk's next-gen obesity drug Cagrisema: investors seek answers

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema amid a lack of clarity over trial results that hammered its shares in December.

Barron's on MSN · 3d

Novo Nordisk Expects Positive News on Weight-Loss Drugs, Soon, From FDA

The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from legally selling cheap knockoff versions.

2don MSN

The Obesity Market Is Growing Just Fine. But Investors Want to Know What’s Next

Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...

News Medical on MSN2d

Can parents' diet predict childhood obesity? New research weighs in

Children’s eating habits are strongly influenced by their parents' weight status, with those having overweight or obese ...

2don MSN

Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

Rolling Out9d

Shocking health risks linked to obesity revealed

Comprehensive study exposes critical health risks of obesity, including diabetes, heart disease, and cancer, while offering ...

4don MSN

Amgen Discloses FDA Paused Study of Early-Stage Obesity Drug

Amgen Inc. sees the potential for 2025 revenues to top Wall Street estimates thanks to growth in cholesterol and cancer drugs ...

News Medical on MSN4d

Ultra-processed foods linked to increased obesity risk in preschoolers

Ultraprocessed food consumption in preschoolers is associated with increased body fat, particularly in boys, underscoring the ...

fingerlakes14d

Obesity Crisis in the Finger Lakes: Health, Economic, and Social Impacts

The economic burden of obesity is also significant. In the Finger Lakes, excess medical spending due to obesity is estimated ...

Medscape5d

Older Anti-Obesity Meds Offer Options Amid Low Access to GLP-1s

While older anti-obesity drugs may lead to less weight loss than semaglutide and tirzepatide, they remain useful tools in ...

Half of Americans Support Weight-Loss Drugs Like Ozempic for Obesity, Poll

Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...

Science Daily2d

Obesity News

Jan. 27, 2025 — A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future ... Signposting Children to ...

thecardiologyadvisor.com1d

Benefits of Pediatric Obesity Treatment Endure Into Young Adulthood

A positive response to treatment for pediatric obesity has enduring health benefits into young adulthood, according to a study.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results